These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2107234)

  • 1. Plasma fibronectin concentrations in blood products.
    Perttilä J; Salo M; Peltola O
    Intensive Care Med; 1990; 16(1):41-3. PubMed ID: 2107234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin in liquid and frozen stored blood components.
    Snyder EL; Ferri PM; Mosher DF
    Transfusion; 1984; 24(1):53-6. PubMed ID: 6420955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive loss of fibronectin-mediated opsonic activity in plasma cryoprecipitate with storage. Role of fibronectin fragmentation.
    Blumenstock FA; Valeri CR; Saba TM; Cho E; Melaragno A; Gray A; Lewis M
    Vox Sang; 1988; 54(3):129-37. PubMed ID: 3369134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin in blood products--an in vitro and in vivo study.
    Reilly JT; McVerry BA; Mackie MJ
    J Clin Pathol; 1983 Dec; 36(12):1377-81. PubMed ID: 6418769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients.
    Saba TM; Albert WH; Blumenstock FA; Evanega G; Staehler F; Cho E
    J Lab Clin Med; 1981 Oct; 98(4):482-91. PubMed ID: 7288265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
    Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
    Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.
    Saba TM; Niehaus GD; Scovill WA; Blumenstock FA; Newell JC; Holman J; Powers SR
    Ann Surg; 1983 Nov; 198(5):654-62. PubMed ID: 6416192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factor VIII-rich cryoprecipitate and the plasma fibronectin-rich, heparin-precipitable fraction prepared from single-donor plasma units.
    Menitove JE; Amrani DL; Meh D; Frenzke M; Mosesson MW
    Transfusion; 1987; 27(6):491-5. PubMed ID: 3500532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of fibronectin and opsonic deficiency in patients. A controlled study.
    Saba TM; Blumenstock FA; Shah DM; Kaplan JE; Cho E; Scovill W; Stratton H; Newell J; Gottlieb M; Sedransk N
    Ann Surg; 1984 Jan; 199(1):87-96. PubMed ID: 6362585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fibronectin-rich human cryoprecipitate on fluid volume requirements in sheep during postoperative sepsis.
    Holman JM; Saba TM; Lewis E
    J Trauma; 1988 May; 28(5):571-81. PubMed ID: 3130490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibronectin levels in clinical disease states and after cryoprecipitate infusion.
    Ragni MV; Lewis JH; Spero JA; Bontempo FA
    Thromb Haemost; 1984 Dec; 52(3):321-4. PubMed ID: 6442471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of whole blood storage on factor VIII recovery in fresh frozen plasma and cryoprecipitate.
    Allersma DP; Imambaks RM; Meerhof LJ
    Vox Sang; 1996; 71(3):150-4. PubMed ID: 8912457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
    Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
    Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.